12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersSharps Technology (NASDAQ:STSS) stock increased by 56.5% to $0.4 during Wednesday's after-market session. The market value of their outstanding shares is at $6.3 million. Geovax Labs (NASDAQ:GO
NexImmune | 10-Q: Quarterly report
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 123.5% to $1.14 during Thursday's pre-market session. The market value of their outstanding shares is at $2.0 million. SINTX Techs
NexImmune Announces Leadership Shift in Financial Management
Express News | NexImmune Inc: Appointed Albert N. Marchio II As Interim CFO
XXII, GRIN and XTIA Are Among Mid-day Movers
Rentokil Initial, Avangrid, American Eagle Outfitters Among Premarket Gainers' Pack
Express News | NexImmune Has Received A Decision To Grant European Patent Number EP3970748 Titled "Nanoparticle Compositions And Methods For Immunotherapy"
12 Health Care Stocks Moving In Monday's After-Market Session
GainersTrxade Health (NASDAQ:MEDS) stock rose 105.3% to $8.5 during Monday's after-market session. The company's market cap stands at $10.2 million. Iovance Biotherapeutics (NASDAQ:IOVA) shares moved
NexImmune Announces New Offerings in Recent Press Release
NexImmune Delays Liquidation Vote for Financing Review
NexImmune Equity Sales: Unregistered Securities and Private Placement
NexImmune Secures Funding Through Equity and Warrant Sales
TRUG, NVFY and ALTM Among Pre-market Losers
NexImmune Ends Stock Sale Agreement, Raises $5.1 Million
NexImmune Slips After Securities Offering
Express News | NexImmune Announces $3.67M Registered Direct Offering Of 304,731 Shares At $12.05/Share
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GAITHERSBURG, Md., Feb. 02, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of
Conmed, Relmada Therapeutics Among Healthcare Movers
IFBD, BFRG and GHSI Among Pre-market Losers
No Data